HEADER APOPTOSIS 09-NOV-08 3F7I TITLE STRUCTURE OF AN ML-IAP/XIAP CHIMERA BOUND TO A PEPTIDOMIMETIC COMPND MOL_ID: 1; COMPND 2 MOLECULE: BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 7; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: ML-IAP RESIDUES 63-172; COMPND 5 SYNONYM: KIDNEY INHIBITOR OF APOPTOSIS PROTEIN, KIAP, MELANOMA COMPND 6 INHIBITOR OF APOPTOSIS PROTEIN, ML-IAP, LIVIN, RING FINGER PROTEIN COMPND 7 50; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BIRC7, KIAP, LIVIN, MLIAP, RNF50, UNQ5800/PRO19607/PRO21344; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS ZINC BINDING, PEPTIDE COMPLEX, APOPTOSIS INHIBITION, PEPTIDOMIMETIC, KEYWDS 2 SMALL MOLECULE, DRUG DESIGN, APOPTOSIS, METAL-BINDING, NUCLEUS, KEYWDS 3 ZINC-FINGER EXPDTA X-RAY DIFFRACTION AUTHOR M.C.FRANKLIN,W.J.FAIRBROTHER,F.COHEN REVDAT 7 03-APR-24 3F7I 1 REMARK REVDAT 6 27-DEC-23 3F7I 1 REMARK REVDAT 5 20-OCT-21 3F7I 1 REMARK SEQADV LINK REVDAT 4 25-OCT-17 3F7I 1 REMARK REVDAT 3 13-JUL-11 3F7I 1 VERSN REVDAT 2 31-MAR-09 3F7I 1 JRNL REVDAT 1 17-MAR-09 3F7I 0 JRNL AUTH F.COHEN,B.ALICKE,L.O.ELLIOTT,J.A.FLYGARE,T.GONCHAROV, JRNL AUTH 2 S.F.KETELTAS,M.C.FRANKLIN,S.FRANKOVITZ,J.P.STEPHAN,V.TSUI, JRNL AUTH 3 D.VUCIC,H.WONG,W.J.FAIRBROTHER JRNL TITL ORALLY BIOAVAILABLE ANTAGONISTS OF INHIBITOR OF APOPTOSIS JRNL TITL 2 PROTEINS BASED ON AN AZABICYCLOOCTANE SCAFFOLD JRNL REF J.MED.CHEM. V. 52 1723 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19228017 JRNL DOI 10.1021/JM801450C REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH K.ZOBEL,L.WANG,E.VARFOLOMEEV,M.C.FRANKLIN,L.O.ELLIOTT, REMARK 1 AUTH 2 H.J.WALLWEBER,D.C.OKAWA,J.A.FLYGARE,D.VUCIC,W.J.FAIRBROTHER, REMARK 1 AUTH 3 K.DESHAYES REMARK 1 TITL DESIGN, SYNTHESIS, AND BIOLOGICAL ACTIVITY OF A POTENT SMAC REMARK 1 TITL 2 MIMETIC THAT SENSITIZES CANCER CELLS TO APOPTOSIS BY REMARK 1 TITL 3 ANTAGONIZING IAPS. REMARK 1 REF ACS CHEM. BIOL. V. 1 525 2006 REMARK 1 REFN ISSN 1554-8929 REMARK 1 PMID 17168540 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.VUCIC,M.C.FRANKLIN,H.J.WALLWEBER,K.DAS,B.P.ECKELMAN, REMARK 1 AUTH 2 H.SHIN,L.O.ELLIOTT,K.DESHAYES,G.S.SALVESEN,W.J.FAIRBROTHER REMARK 1 TITL ENGINEERING ML-IAP TO PRODUCE AN EXTRAORDINARILY POTENT REMARK 1 TITL 2 CASPASE-9 INHIBITOR: IMPLICATIONS FOR SMAC-DEPENDENT REMARK 1 TITL 3 ANTI-APOPTOTIC ACTIVITY OF ML-IAP. REMARK 1 REF BIOCHEM. J. V. 385 11 2005 REMARK 1 REFN ISSN 0264-6021 REMARK 1 PMID 15485396 REMARK 1 REFERENCE 3 REMARK 1 AUTH M.C.FRANKLIN,S.KADKHODAYAN,H.ACKERLY,D.ALEXANDRU, REMARK 1 AUTH 2 M.D.DISTEFANO,L.O.ELLIOTT,J.A.FLYGARE,D.VUCIC,K.DESHAYES, REMARK 1 AUTH 3 W.J.FAIRBROTHER REMARK 1 TITL STRUCTURE AND FUNCTION ANALYSIS OF PEPTIDE ANTAGONISTS OF REMARK 1 TITL 2 MELANOMA INHIBITOR OF APOPTOSIS (ML-IAP) REMARK 1 REF BIOCHEMISTRY V. 42 8223 2003 REMARK 1 REFN ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 21754 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.156 REMARK 3 R VALUE (WORKING SET) : 0.155 REMARK 3 FREE R VALUE : 0.181 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1146 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1547 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2020 REMARK 3 BIN FREE R VALUE SET COUNT : 93 REMARK 3 BIN FREE R VALUE : 0.2810 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1479 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 95 REMARK 3 SOLVENT ATOMS : 198 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 17.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.57 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.67000 REMARK 3 B22 (A**2) : -0.67000 REMARK 3 B33 (A**2) : 1.34000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.104 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.100 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.064 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.278 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.953 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1645 ; 0.008 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 1148 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2226 ; 1.134 ; 1.984 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2743 ; 0.801 ; 3.004 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 181 ; 4.375 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 79 ;34.440 ;23.038 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 220 ;12.425 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ;10.202 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 208 ; 0.064 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1809 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 382 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 344 ; 0.201 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1200 ; 0.189 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 788 ; 0.189 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 713 ; 0.081 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 138 ; 0.133 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 8 ; 0.076 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 33 ; 0.258 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 28 ; 0.156 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1174 ; 1.668 ; 2.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 370 ; 0.289 ; 2.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1446 ; 1.922 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 924 ; 1.628 ; 2.500 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 780 ; 2.505 ; 5.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 78 A 167 REMARK 3 RESIDUE RANGE : A 1001 A 1001 REMARK 3 ORIGIN FOR THE GROUP (A): 84.6128 68.0401 22.4991 REMARK 3 T TENSOR REMARK 3 T11: -0.1711 T22: -0.1590 REMARK 3 T33: -0.1665 T12: -0.0033 REMARK 3 T13: 0.0080 T23: 0.0043 REMARK 3 L TENSOR REMARK 3 L11: 2.5097 L22: 3.0086 REMARK 3 L33: 2.0599 L12: -0.5450 REMARK 3 L13: -0.3145 L23: -0.2164 REMARK 3 S TENSOR REMARK 3 S11: 0.0447 S12: 0.1580 S13: -0.0043 REMARK 3 S21: -0.2716 S22: -0.0223 S23: -0.0649 REMARK 3 S31: 0.0037 S32: 0.0191 S33: -0.0225 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 78 B 171 REMARK 3 RESIDUE RANGE : B 1001 B 1001 REMARK 3 ORIGIN FOR THE GROUP (A): 77.9468 59.7263 50.2387 REMARK 3 T TENSOR REMARK 3 T11: -0.1780 T22: -0.1712 REMARK 3 T33: -0.1648 T12: -0.0176 REMARK 3 T13: 0.0137 T23: -0.0004 REMARK 3 L TENSOR REMARK 3 L11: 1.4649 L22: 2.9662 REMARK 3 L33: 1.8183 L12: -0.6503 REMARK 3 L13: 0.5923 L23: -1.0756 REMARK 3 S TENSOR REMARK 3 S11: 0.0092 S12: -0.1074 S13: -0.0137 REMARK 3 S21: 0.1620 S22: -0.0248 S23: -0.0249 REMARK 3 S31: -0.0329 S32: 0.0096 S33: 0.0156 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 1 REMARK 3 ORIGIN FOR THE GROUP (A): 78.2317 62.3793 15.2868 REMARK 3 T TENSOR REMARK 3 T11: 0.0257 T22: -0.0200 REMARK 3 T33: -0.1053 T12: -0.0402 REMARK 3 T13: -0.1077 T23: 0.0273 REMARK 3 L TENSOR REMARK 3 L11: 1.2682 L22: 9.1482 REMARK 3 L33: 22.7654 L12: 3.4039 REMARK 3 L13: -0.8788 L23: -2.8796 REMARK 3 S TENSOR REMARK 3 S11: -0.1345 S12: 1.0789 S13: 0.2447 REMARK 3 S21: -1.1748 S22: 0.2590 S23: 0.8922 REMARK 3 S31: 0.5428 S32: -1.5755 S33: -0.1245 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 1 REMARK 3 ORIGIN FOR THE GROUP (A): 68.4422 54.6548 48.0143 REMARK 3 T TENSOR REMARK 3 T11: -0.1429 T22: -0.1728 REMARK 3 T33: -0.0874 T12: -0.0137 REMARK 3 T13: 0.0102 T23: 0.0371 REMARK 3 L TENSOR REMARK 3 L11: 7.7427 L22: 25.6312 REMARK 3 L33: 3.2847 L12: 3.6851 REMARK 3 L13: 4.0613 L23: -3.3171 REMARK 3 S TENSOR REMARK 3 S11: 0.2302 S12: 0.0407 S13: -0.2862 REMARK 3 S21: -0.2420 S22: -0.4291 S23: 0.4058 REMARK 3 S31: 1.1680 S32: -0.2467 S33: 0.1989 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3F7I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-NOV-08. REMARK 100 THE DEPOSITION ID IS D_1000050243. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-DEC-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : OSMIC MIRRORS REMARK 200 OPTICS : OSMIC BLUE REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22958 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.600 REMARK 200 R MERGE (I) : 0.11900 REMARK 200 R SYM (I) : 0.11900 REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : 0.64600 REMARK 200 R SYM FOR SHELL (I) : 0.64600 REMARK 200 FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: DIFFERENCE FOURIER REMARK 200 STARTING MODEL: 1.3 A STRUCTURE OF THE ML-IAP/XIAP PROTEIN BOUND REMARK 200 TO A DIFFERENT PEPTIDOMIMETIC, WITH THE LIGAND AND SURROUNDING REMARK 200 WATERS REMOVED REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: LITHIUM SULFATE, PEG 3350, BIS-TRIS, REMARK 280 PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.84250 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 43.58150 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 43.58150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 18.42125 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 43.58150 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 43.58150 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 55.26375 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 43.58150 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.58150 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 18.42125 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 43.58150 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.58150 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 55.26375 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 36.84250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT EACH ASYMMETRIC UNIT CONTAINS TWO REMARK 300 BIOLOGICAL ASSEMBLIES OF PROTEIN AND LIGAND REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 182 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 40 REMARK 465 GLY A 41 REMARK 465 SER A 42 REMARK 465 SER A 43 REMARK 465 HIS A 44 REMARK 465 HIS A 45 REMARK 465 HIS A 46 REMARK 465 HIS A 47 REMARK 465 HIS A 48 REMARK 465 HIS A 49 REMARK 465 SER A 50 REMARK 465 SER A 51 REMARK 465 GLY A 52 REMARK 465 GLU A 53 REMARK 465 VAL A 54 REMARK 465 PRO A 55 REMARK 465 ARG A 56 REMARK 465 GLY A 57 REMARK 465 SER A 58 REMARK 465 HIS A 59 REMARK 465 MET A 60 REMARK 465 LEU A 61 REMARK 465 GLU A 62 REMARK 465 THR A 63 REMARK 465 GLU A 64 REMARK 465 GLU A 65 REMARK 465 GLU A 66 REMARK 465 GLU A 67 REMARK 465 GLU A 68 REMARK 465 GLU A 69 REMARK 465 GLY A 70 REMARK 465 ALA A 71 REMARK 465 GLY A 72 REMARK 465 ALA A 73 REMARK 465 THR A 74 REMARK 465 LEU A 75 REMARK 465 SER A 76 REMARK 465 ARG A 77 REMARK 465 LEU A 168 REMARK 465 THR A 169 REMARK 465 HIS A 170 REMARK 465 SER A 171 REMARK 465 LEU A 172 REMARK 465 MET B 40 REMARK 465 GLY B 41 REMARK 465 SER B 42 REMARK 465 SER B 43 REMARK 465 HIS B 44 REMARK 465 HIS B 45 REMARK 465 HIS B 46 REMARK 465 HIS B 47 REMARK 465 HIS B 48 REMARK 465 HIS B 49 REMARK 465 SER B 50 REMARK 465 SER B 51 REMARK 465 GLY B 52 REMARK 465 GLU B 53 REMARK 465 VAL B 54 REMARK 465 PRO B 55 REMARK 465 ARG B 56 REMARK 465 GLY B 57 REMARK 465 SER B 58 REMARK 465 HIS B 59 REMARK 465 MET B 60 REMARK 465 LEU B 61 REMARK 465 GLU B 62 REMARK 465 THR B 63 REMARK 465 GLU B 64 REMARK 465 GLU B 65 REMARK 465 GLU B 66 REMARK 465 GLU B 67 REMARK 465 GLU B 68 REMARK 465 GLU B 69 REMARK 465 GLY B 70 REMARK 465 ALA B 71 REMARK 465 GLY B 72 REMARK 465 ALA B 73 REMARK 465 THR B 74 REMARK 465 LEU B 75 REMARK 465 SER B 76 REMARK 465 ARG B 77 REMARK 465 SER B 171 REMARK 465 LEU B 172 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 25 O HOH A 199 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 197 O HOH B 278 7556 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 119 -134.81 47.65 REMARK 500 GLN B 119 -142.93 49.22 REMARK 500 TYR B 128 -12.13 77.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 124 SG REMARK 620 2 CYS A 127 SG 105.8 REMARK 620 3 HIS A 144 NE2 100.3 117.5 REMARK 620 4 CYS A 151 SG 118.8 108.4 106.5 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 LI B1002 LI REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER B 93 O REMARK 620 2 ASP B 96 OD1 117.0 REMARK 620 3 HIS B 115 ND1 119.9 101.1 REMARK 620 4 EDO B 174 O2 92.6 108.4 118.2 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1001 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 124 SG REMARK 620 2 CYS B 127 SG 106.9 REMARK 620 3 HIS B 144 NE2 99.4 119.6 REMARK 620 4 CYS B 151 SG 117.6 106.7 107.2 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G13 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LI B 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G13 B 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BTB B 173 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 174 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 175 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1TW6 RELATED DB: PDB REMARK 900 RELATED ID: 2I3H RELATED DB: PDB REMARK 900 RELATED ID: 2I3I RELATED DB: PDB REMARK 900 RELATED ID: 3F7G RELATED DB: PDB REMARK 900 RELATED ID: 3F7H RELATED DB: PDB DBREF 3F7I A 63 172 UNP Q6R308 Q6R308_HUMAN 63 172 DBREF 3F7I B 63 172 UNP Q6R308 Q6R308_HUMAN 63 172 SEQADV 3F7I MET A 40 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLY A 41 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER A 42 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER A 43 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS A 44 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS A 45 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS A 46 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS A 47 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS A 48 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS A 49 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER A 50 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER A 51 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLY A 52 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLU A 53 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I VAL A 54 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I PRO A 55 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I ARG A 56 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLY A 57 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER A 58 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS A 59 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I MET A 60 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I LEU A 61 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLU A 62 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLY A 150 UNP Q6R308 SER 150 ENGINEERED MUTATION SEQADV 3F7I GLN A 160 UNP Q6R308 ARG 160 ENGINEERED MUTATION SEQADV 3F7I GLU A 161 UNP Q6R308 ASP 161 ENGINEERED MUTATION SEQADV 3F7I TYR A 162 UNP Q6R308 PHE 162 ENGINEERED MUTATION SEQADV 3F7I ILE A 163 UNP Q6R308 VAL 163 ENGINEERED MUTATION SEQADV 3F7I ASN A 164 UNP Q6R308 HIS 164 ENGINEERED MUTATION SEQADV 3F7I ASN A 165 UNP Q6R308 SER 165 ENGINEERED MUTATION SEQADV 3F7I ILE A 166 UNP Q6R308 VAL 166 ENGINEERED MUTATION SEQADV 3F7I HIS A 167 UNP Q6R308 GLN 167 ENGINEERED MUTATION SEQADV 3F7I LEU A 168 UNP Q6R308 GLU 168 ENGINEERED MUTATION SEQADV 3F7I LEU A 172 UNP Q6R308 GLN 172 ENGINEERED MUTATION SEQADV 3F7I MET B 40 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLY B 41 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER B 42 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER B 43 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS B 44 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS B 45 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS B 46 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS B 47 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS B 48 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS B 49 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER B 50 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER B 51 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLY B 52 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLU B 53 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I VAL B 54 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I PRO B 55 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I ARG B 56 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLY B 57 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I SER B 58 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I HIS B 59 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I MET B 60 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I LEU B 61 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLU B 62 UNP Q6R308 EXPRESSION TAG SEQADV 3F7I GLY B 150 UNP Q6R308 SER 150 ENGINEERED MUTATION SEQADV 3F7I GLN B 160 UNP Q6R308 ARG 160 ENGINEERED MUTATION SEQADV 3F7I GLU B 161 UNP Q6R308 ASP 161 ENGINEERED MUTATION SEQADV 3F7I TYR B 162 UNP Q6R308 PHE 162 ENGINEERED MUTATION SEQADV 3F7I ILE B 163 UNP Q6R308 VAL 163 ENGINEERED MUTATION SEQADV 3F7I ASN B 164 UNP Q6R308 HIS 164 ENGINEERED MUTATION SEQADV 3F7I ASN B 165 UNP Q6R308 SER 165 ENGINEERED MUTATION SEQADV 3F7I ILE B 166 UNP Q6R308 VAL 166 ENGINEERED MUTATION SEQADV 3F7I HIS B 167 UNP Q6R308 GLN 167 ENGINEERED MUTATION SEQADV 3F7I LEU B 168 UNP Q6R308 GLU 168 ENGINEERED MUTATION SEQADV 3F7I LEU B 172 UNP Q6R308 GLN 172 ENGINEERED MUTATION SEQRES 1 A 133 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 133 GLU VAL PRO ARG GLY SER HIS MET LEU GLU THR GLU GLU SEQRES 3 A 133 GLU GLU GLU GLU GLY ALA GLY ALA THR LEU SER ARG GLY SEQRES 4 A 133 PRO ALA PHE PRO GLY MET GLY SER GLU GLU LEU ARG LEU SEQRES 5 A 133 ALA SER PHE TYR ASP TRP PRO LEU THR ALA GLU VAL PRO SEQRES 6 A 133 PRO GLU LEU LEU ALA ALA ALA GLY PHE PHE HIS THR GLY SEQRES 7 A 133 HIS GLN ASP LYS VAL ARG CYS PHE PHE CYS TYR GLY GLY SEQRES 8 A 133 LEU GLN SER TRP LYS ARG GLY ASP ASP PRO TRP THR GLU SEQRES 9 A 133 HIS ALA LYS TRP PHE PRO GLY CYS GLN PHE LEU LEU ARG SEQRES 10 A 133 SER LYS GLY GLN GLU TYR ILE ASN ASN ILE HIS LEU THR SEQRES 11 A 133 HIS SER LEU SEQRES 1 B 133 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 133 GLU VAL PRO ARG GLY SER HIS MET LEU GLU THR GLU GLU SEQRES 3 B 133 GLU GLU GLU GLU GLY ALA GLY ALA THR LEU SER ARG GLY SEQRES 4 B 133 PRO ALA PHE PRO GLY MET GLY SER GLU GLU LEU ARG LEU SEQRES 5 B 133 ALA SER PHE TYR ASP TRP PRO LEU THR ALA GLU VAL PRO SEQRES 6 B 133 PRO GLU LEU LEU ALA ALA ALA GLY PHE PHE HIS THR GLY SEQRES 7 B 133 HIS GLN ASP LYS VAL ARG CYS PHE PHE CYS TYR GLY GLY SEQRES 8 B 133 LEU GLN SER TRP LYS ARG GLY ASP ASP PRO TRP THR GLU SEQRES 9 B 133 HIS ALA LYS TRP PHE PRO GLY CYS GLN PHE LEU LEU ARG SEQRES 10 B 133 SER LYS GLY GLN GLU TYR ILE ASN ASN ILE HIS LEU THR SEQRES 11 B 133 HIS SER LEU HET ZN A1001 1 HET G13 A 1 35 HET ZN B1001 1 HET LI B1002 1 HET G13 B 1 35 HET BTB B 173 14 HET EDO B 174 4 HET EDO B 175 4 HETNAM ZN ZINC ION HETNAM G13 N-[(3AR,6S,6AS)-1-(N-METHYL-L-ALANYL-3-METHYL-L-VALYL) HETNAM 2 G13 OCTAHYDROCYCLOPENTA[B]PYRROL-6-YL]NAPHTHALENE-1- HETNAM 3 G13 CARBOXAMIDE HETNAM LI LITHIUM ION HETNAM BTB 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL- HETNAM 2 BTB PROPANE-1,3-DIOL HETNAM EDO 1,2-ETHANEDIOL HETSYN BTB BIS-TRIS BUFFER HETSYN EDO ETHYLENE GLYCOL FORMUL 3 ZN 2(ZN 2+) FORMUL 4 G13 2(C28 H38 N4 O3) FORMUL 6 LI LI 1+ FORMUL 8 BTB C8 H19 N O5 FORMUL 9 EDO 2(C2 H6 O2) FORMUL 11 HOH *198(H2 O) HELIX 1 1 PHE A 81 GLY A 85 5 5 HELIX 2 2 SER A 86 SER A 93 1 8 HELIX 3 3 PRO A 104 ALA A 111 1 8 HELIX 4 4 ASP A 139 PHE A 148 1 10 HELIX 5 5 CYS A 151 GLY A 159 1 9 HELIX 6 6 GLY A 159 HIS A 167 1 9 HELIX 7 7 PHE B 81 GLY B 85 5 5 HELIX 8 8 SER B 86 SER B 93 1 8 HELIX 9 9 PHE B 94 TRP B 97 5 4 HELIX 10 10 PRO B 104 ALA B 111 1 8 HELIX 11 11 ASP B 139 PHE B 148 1 10 HELIX 12 12 CYS B 151 GLY B 159 1 9 HELIX 13 13 GLY B 159 HIS B 170 1 12 SHEET 1 A 3 PHE A 113 HIS A 115 0 SHEET 2 A 3 VAL A 122 CYS A 124 -1 O ARG A 123 N PHE A 114 SHEET 3 A 3 GLY A 130 LEU A 131 -1 O LEU A 131 N VAL A 122 SHEET 1 B 3 PHE B 113 HIS B 115 0 SHEET 2 B 3 VAL B 122 CYS B 124 -1 O ARG B 123 N PHE B 114 SHEET 3 B 3 GLY B 130 LEU B 131 -1 O LEU B 131 N VAL B 122 LINK SG CYS A 124 ZN ZN A1001 1555 1555 2.33 LINK SG CYS A 127 ZN ZN A1001 1555 1555 2.34 LINK NE2 HIS A 144 ZN ZN A1001 1555 1555 2.08 LINK SG CYS A 151 ZN ZN A1001 1555 1555 2.31 LINK O SER B 93 LI LI B1002 1555 1555 1.84 LINK OD1 ASP B 96 LI LI B1002 1555 1555 1.81 LINK ND1 HIS B 115 LI LI B1002 1555 1555 1.93 LINK SG CYS B 124 ZN ZN B1001 1555 1555 2.33 LINK SG CYS B 127 ZN ZN B1001 1555 1555 2.31 LINK NE2 HIS B 144 ZN ZN B1001 1555 1555 2.10 LINK SG CYS B 151 ZN ZN B1001 1555 1555 2.31 LINK O2 EDO B 174 LI LI B1002 1555 1555 1.81 SITE 1 AC1 4 CYS A 124 CYS A 127 HIS A 144 CYS A 151 SITE 1 AC2 10 LYS A 121 GLY A 130 LEU A 131 GLN A 132 SITE 2 AC2 10 SER A 133 TRP A 134 ASP A 138 GLU A 143 SITE 3 AC2 10 TRP A 147 HOH A 289 SITE 1 AC3 4 CYS B 124 CYS B 127 HIS B 144 CYS B 151 SITE 1 AC4 4 SER B 93 ASP B 96 HIS B 115 EDO B 174 SITE 1 AC5 13 GLU A 106 LYS B 121 GLY B 130 LEU B 131 SITE 2 AC5 13 GLN B 132 SER B 133 ASP B 138 GLU B 143 SITE 3 AC5 13 TRP B 147 HOH B 196 HOH B 274 HOH B 276 SITE 4 AC5 13 HOH B 283 SITE 1 AC6 8 PRO B 82 GLY B 83 SER B 86 LYS B 146 SITE 2 AC6 8 TRP B 147 HIS B 167 HIS B 170 HOH B 268 SITE 1 AC7 8 SER A 93 HOH A 232 SER B 93 ASP B 96 SITE 2 AC7 8 HIS B 115 GLY B 117 HOH B 258 LI B1002 SITE 1 AC8 5 CYS B 127 PHE B 148 PRO B 149 GLY B 150 SITE 2 AC8 5 HOH B 183 CRYST1 87.163 87.163 73.685 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011473 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011473 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013571 0.00000